Collectively, these mechanisms converge to enable critical cancer phenotypes, including drug resistance (e.g., via glycolysis and autophagy regulation), immune evasion (e.g., through PD-1/PD-L1 axis modulation), and metastasis and angiogenesis. This evidence concerns the gene PDCD1 and cancer.